JP2011501943A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011501943A5 JP2011501943A5 JP2010529072A JP2010529072A JP2011501943A5 JP 2011501943 A5 JP2011501943 A5 JP 2011501943A5 JP 2010529072 A JP2010529072 A JP 2010529072A JP 2010529072 A JP2010529072 A JP 2010529072A JP 2011501943 A5 JP2011501943 A5 JP 2011501943A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- esophagus
- group
- tissue
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 43
- 210000001519 tissue Anatomy 0.000 claims 41
- 239000000090 biomarker Substances 0.000 claims 32
- 208000023514 Barrett esophagus Diseases 0.000 claims 29
- 208000023665 Barrett oesophagus Diseases 0.000 claims 29
- 208000009956 adenocarcinoma Diseases 0.000 claims 21
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 21
- 108091070501 miRNA Proteins 0.000 claims 18
- 208000036764 Adenocarcinoma of the esophagus Diseases 0.000 claims 16
- 206010030137 Oesophageal adenocarcinoma Diseases 0.000 claims 16
- 208000028653 esophageal adenocarcinoma Diseases 0.000 claims 16
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 108091062762 miR-21 stem-loop Proteins 0.000 claims 8
- 108091041631 miR-21-1 stem-loop Proteins 0.000 claims 8
- 108091044442 miR-21-2 stem-loop Proteins 0.000 claims 8
- 108091028141 MiR-203 Proteins 0.000 claims 7
- 108091062154 Mir-205 Proteins 0.000 claims 5
- 108091062140 Mir-223 Proteins 0.000 claims 5
- 208000036765 Squamous cell carcinoma of the esophagus Diseases 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 208000007276 esophageal squamous cell carcinoma Diseases 0.000 claims 5
- 108091032320 miR-146 stem-loop Proteins 0.000 claims 5
- 108091024530 miR-146a stem-loop Proteins 0.000 claims 5
- 108091043612 miR-146b stem-loop Proteins 0.000 claims 5
- 108091007772 MIRLET7C Proteins 0.000 claims 4
- 108091033773 MiR-155 Proteins 0.000 claims 4
- 108091028695 MiR-224 Proteins 0.000 claims 4
- 108091080933 Mir-192/215 microRNA precursor Proteins 0.000 claims 4
- 108091093189 Mir-375 Proteins 0.000 claims 4
- 230000003247 decreasing effect Effects 0.000 claims 4
- 108091037473 miR-103 stem-loop Proteins 0.000 claims 4
- 108091050539 miR-107 stem-loop Proteins 0.000 claims 4
- 108091027943 miR-16 stem-loop Proteins 0.000 claims 4
- 108091054642 miR-194 stem-loop Proteins 0.000 claims 4
- 108091088730 miR-215 stem-loop Proteins 0.000 claims 4
- 108091063344 miR-30b stem-loop Proteins 0.000 claims 4
- 108091055059 miR-30c stem-loop Proteins 0.000 claims 4
- 108091023818 miR-7 stem-loop Proteins 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 108091031103 miR-181a stem-loop Proteins 0.000 claims 3
- 108091046591 miR-181a-4 stem-loop Proteins 0.000 claims 3
- 108091049627 miR-181a-5 stem-loop Proteins 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 108091033433 MiR-191 Proteins 0.000 claims 2
- 108091028066 Mir-126 Proteins 0.000 claims 2
- 108091027766 Mir-143 Proteins 0.000 claims 2
- 108091028684 Mir-145 Proteins 0.000 claims 2
- 108091060302 Mir-320 Proteins 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 108091091807 let-7a stem-loop Proteins 0.000 claims 2
- 108091057746 let-7a-4 stem-loop Proteins 0.000 claims 2
- 108091028376 let-7a-5 stem-loop Proteins 0.000 claims 2
- 108091024393 let-7a-6 stem-loop Proteins 0.000 claims 2
- 108091091174 let-7a-7 stem-loop Proteins 0.000 claims 2
- 108091007423 let-7b Proteins 0.000 claims 2
- 108091033753 let-7d stem-loop Proteins 0.000 claims 2
- 108091042844 let-7i stem-loop Proteins 0.000 claims 2
- 108091028606 miR-1 stem-loop Proteins 0.000 claims 2
- 108091026501 miR-122a stem-loop Proteins 0.000 claims 2
- 108091044988 miR-125a stem-loop Proteins 0.000 claims 2
- 108091049513 miR-125a-1 stem-loop Proteins 0.000 claims 2
- 108091040046 miR-125a-2 stem-loop Proteins 0.000 claims 2
- 108091091360 miR-125b stem-loop Proteins 0.000 claims 2
- 108091079012 miR-133a Proteins 0.000 claims 2
- 108091024038 miR-133a stem-loop Proteins 0.000 claims 2
- 108091045872 miR-135 stem-loop Proteins 0.000 claims 2
- 108091026523 miR-135a stem-loop Proteins 0.000 claims 2
- 108091091751 miR-17 stem-loop Proteins 0.000 claims 2
- 108091069239 miR-17-2 stem-loop Proteins 0.000 claims 2
- 108091055042 miR-181 stem-loop Proteins 0.000 claims 2
- 108091043222 miR-181b stem-loop Proteins 0.000 claims 2
- 108091086416 miR-192 stem-loop Proteins 0.000 claims 2
- 108091063348 miR-193 stem-loop Proteins 0.000 claims 2
- 108091036762 miR-193a stem-loop Proteins 0.000 claims 2
- 108091089775 miR-200b stem-loop Proteins 0.000 claims 2
- 108091045665 miR-202 stem-loop Proteins 0.000 claims 2
- 108091039792 miR-20b stem-loop Proteins 0.000 claims 2
- 108091055878 miR-20b-1 stem-loop Proteins 0.000 claims 2
- 108091027746 miR-20b-2 stem-loop Proteins 0.000 claims 2
- 108091048308 miR-210 stem-loop Proteins 0.000 claims 2
- 108091047189 miR-29c stem-loop Proteins 0.000 claims 2
- 108091054490 miR-29c-2 stem-loop Proteins 0.000 claims 2
- 108091057188 miR-369 stem-loop Proteins 0.000 claims 2
- 108091027983 miR-378-1 stem-loop Proteins 0.000 claims 2
- 108091089716 miR-378-2 stem-loop Proteins 0.000 claims 2
- 108091056170 miR-499 stem-loop Proteins 0.000 claims 2
- 108091050885 miR-499-1 stem-loop Proteins 0.000 claims 2
- 108091038523 miR-499-2 stem-loop Proteins 0.000 claims 2
- 108091030520 miR-7-2 stem-loop Proteins 0.000 claims 2
- 108091059456 miR-92-1 stem-loop Proteins 0.000 claims 2
- 108091084336 miR-92-2 stem-loop Proteins 0.000 claims 2
- 108091032902 miR-93 stem-loop Proteins 0.000 claims 2
- 108091076732 miR-99a stem-loop Proteins 0.000 claims 2
- 108091064318 miR-99a-1 stem-loop Proteins 0.000 claims 2
- 108091086202 miR-99a-2 stem-loop Proteins 0.000 claims 2
- 108091024443 miRa-135-1 stem-loop Proteins 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- 238000011127 radiochemotherapy Methods 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000003238 esophagus Anatomy 0.000 claims 1
- 230000001632 homeopathic effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000010837 poor prognosis Methods 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97930007P | 2007-10-11 | 2007-10-11 | |
| US60/979,300 | 2007-10-11 | ||
| PCT/US2008/079482 WO2009049129A1 (en) | 2007-10-11 | 2008-10-10 | Methods and compositions for the diagnosis and treatment of esphageal adenocarcinomas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011501943A JP2011501943A (ja) | 2011-01-20 |
| JP2011501943A5 true JP2011501943A5 (enExample) | 2011-12-01 |
| JP5723156B2 JP5723156B2 (ja) | 2015-05-27 |
Family
ID=40549579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010529072A Expired - Fee Related JP5723156B2 (ja) | 2007-10-11 | 2008-10-10 | 食道腺癌の診断及び治療のための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100285471A1 (enExample) |
| EP (1) | EP2212440A4 (enExample) |
| JP (1) | JP5723156B2 (enExample) |
| CN (2) | CN101861401B (enExample) |
| AU (1) | AU2008310704B2 (enExample) |
| CA (1) | CA2702241A1 (enExample) |
| WO (1) | WO2009049129A1 (enExample) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103866018B (zh) | 2005-08-01 | 2016-05-25 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
| CN103028120B (zh) | 2005-09-12 | 2015-08-12 | 俄亥俄州立大学研究基金会 | 用于诊断或治疗bcl2相关癌症的组合物和方法 |
| ES2524018T3 (es) | 2006-01-05 | 2014-12-03 | The Ohio State University Research Foundation | Anomalías de la expresión de microARN en tumores pancreáticos endocrinos y acinares |
| WO2007081720A2 (en) | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| EP2487260B1 (en) | 2006-01-05 | 2015-07-08 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis and treatment of solid cancers |
| EP2369012A1 (en) | 2006-03-20 | 2011-09-28 | The Ohio State University Research Foundation | Micro-RNA fingerprints during human megakaryocytopoiesis |
| CA2657030A1 (en) | 2006-07-13 | 2008-01-17 | The Ohio State University Research Foundation, An Instrumentality Of The State Of Ohio | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases |
| US8071292B2 (en) | 2006-09-19 | 2011-12-06 | The Ohio State University Research Foundation | Leukemia diagnostic methods |
| JP5501766B2 (ja) | 2006-11-01 | 2014-05-28 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 肝細胞癌における生存および転移を予測するためのマイクロｒｎａ発現サイン |
| US8034560B2 (en) | 2007-01-31 | 2011-10-11 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia (AML) |
| CA2690144A1 (en) | 2007-06-08 | 2008-12-18 | The Government Of The United States Of America As Represented By The Sec Retary Of Department Of Health And Human Services | Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells |
| US8053186B2 (en) | 2007-06-15 | 2011-11-08 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
| ES2496172T3 (es) | 2007-07-31 | 2014-09-18 | The Ohio State University Research Foundation | Métodos para invertir la metilación por selección dirigida de DNMT3A y DNMT3B |
| AU2008283997B2 (en) | 2007-08-03 | 2014-04-10 | The Ohio State University Research Foundation | Ultraconserved regions encoding ncRNAs |
| CN101836112A (zh) | 2007-08-22 | 2010-09-15 | 俄亥俄州立大学研究基金会 | 用于在人急性白血病中诱导epha7和erk磷酸化的脱调节的方法和组合物 |
| CA2703707A1 (en) | 2007-10-26 | 2009-04-30 | The Ohio State University Research Foundation | Methods for identifying fragile histidine triad (fhit) interaction and uses thereof |
| CN101878313A (zh) * | 2007-10-30 | 2010-11-03 | 维里德克斯有限责任公司 | 预测鳞状细胞肺癌的方法 |
| AU2009257410B2 (en) | 2008-06-11 | 2014-03-06 | Fudan University | Use of miR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy |
| TWI394839B (zh) | 2008-10-27 | 2013-05-01 | Qiagen Gaithersburg Inc | 快速結果雜交捕捉法及系統 |
| WO2010102226A1 (en) * | 2009-03-05 | 2010-09-10 | Brown University | Methods of diagnosing and treating carcinomas |
| EP2283846A1 (en) * | 2009-08-12 | 2011-02-16 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | miRNA compounds for treatment of prostate carcinoma |
| JP5960060B2 (ja) | 2009-11-23 | 2016-08-02 | ジ・オハイオ・ステート・ユニバーシティ | 腫瘍細胞の増殖、遊走および浸潤に影響を与えるために有用な物質および方法 |
| WO2012065049A1 (en) | 2010-11-12 | 2012-05-18 | The Ohio State University Research Foundation | Materials and methods related to microrna-21, mismatch repair, and colorectal cancer |
| CA2817982C (en) | 2010-11-15 | 2020-06-30 | The Regents Of The University Of Michigan | Controlled release mucoadhesive systems |
| US8664192B2 (en) | 2011-03-07 | 2014-03-04 | The Ohio State University | Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer |
| US20140031258A1 (en) * | 2011-03-28 | 2014-01-30 | The Johns Hopkins University | Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and esophageal adenocarcinoma (eac) |
| WO2013033165A2 (en) * | 2011-08-29 | 2013-03-07 | University Of Miami | Compositions, kits and methods for treating obesity, diabetes and hyperglycemia |
| WO2013029116A1 (en) * | 2011-08-31 | 2013-03-07 | Monash University | Method for predicting treatment responsiveness |
| US20130078632A1 (en) * | 2011-09-23 | 2013-03-28 | Academisch Medisch Centrum | Materials and methods for prognosis of progression of barrett's esophagus |
| EP2766500A4 (en) | 2011-10-14 | 2015-10-14 | Univ Ohio State | METHOD AND MATERIALS IN CONNECTION WITH EGG CANCER |
| WO2013066678A1 (en) * | 2011-10-26 | 2013-05-10 | Georgetown University | Microrna expression profiling of thyroid cancer |
| CA2858382A1 (en) * | 2011-12-10 | 2013-06-13 | Ohio State Innovation Foundation | Mirnas useful to reduce lung cancer tumorigenesis and chemotherapy resistance and related compositons and methods |
| CN104619353A (zh) | 2011-12-13 | 2015-05-13 | 俄亥俄州国家创新基金会 | 与miR-21和miR-29a相关的方法和组合物、外切体抑制和癌症转移 |
| JP2015511121A (ja) | 2012-01-20 | 2015-04-16 | ジ・オハイオ・ステート・ユニバーシティ | 浸潤性および予後に関する乳がんバイオマーカーシグネチャー |
| KR101445560B1 (ko) * | 2012-05-10 | 2014-09-29 | 한국수력원자력 주식회사 | 저준위 전리방사선에 민감한 유전자 검출 방법 및 상기 방법으로 검출된 유전자 |
| WO2014100216A1 (en) * | 2012-12-19 | 2014-06-26 | The Regents Of The University Of California | Cancer-Associated MicroRNAs and Related Antibodies |
| GB201303078D0 (en) * | 2013-02-21 | 2013-04-10 | Cambridge Entpr Ltd | Methods |
| AU2014268417A1 (en) * | 2013-05-23 | 2015-11-26 | Iphenotype Llc | Methods and systems for assisting persons, product providers and/or service providers |
| US10323067B2 (en) | 2014-05-14 | 2019-06-18 | Evorx Technologies, Inc. | Methods and compositions for controlling gene expression and treating cancer |
| CN111910002B (zh) * | 2014-06-18 | 2024-04-12 | 东丽株式会社 | 食道癌的检测试剂盒或装置以及检测方法 |
| CN105368822A (zh) * | 2014-08-29 | 2016-03-02 | 香港大学 | 一种miRNA标记物、其方法和应用 |
| CN104774929B (zh) * | 2015-03-18 | 2017-06-30 | 中山大学肿瘤防治中心 | miR‑455‑3p在食管鳞状细胞癌中的诊断、治疗和预后的应用 |
| KR101657033B1 (ko) * | 2016-03-25 | 2016-09-13 | 성균관대학교산학협력단 | V-ATPase subunit V1E1의 단백질 발현 수준을 측정하여 식도암 환자의 생존율과 예후를 예측하는 방법 |
| CN106177994A (zh) * | 2016-07-18 | 2016-12-07 | 浙江大学 | miR‑1在制备治疗胃癌和乳腺癌药物中的应用 |
| KR20190077309A (ko) * | 2016-08-04 | 2019-07-03 | 베일러 리서치 인스티튜트 | 식도암 진단 및 치료 방법 |
| CN106119392B (zh) * | 2016-08-25 | 2019-12-31 | 朱伟 | 一种与食管鳞癌辅助诊断相关的血清miRNA标志物及其应用 |
| US11584932B2 (en) | 2016-11-01 | 2023-02-21 | The Research Foundation For The State University Of New York | 5-halouracil-modified microRNAs and their use in the treatment of cancer |
| CN108103201B (zh) * | 2018-03-05 | 2022-03-01 | 江苏为真生物医药技术股份有限公司 | 外泌体microRNA分子标志物的应用及用于诊断食管癌的试剂盒 |
| CN108828229B (zh) * | 2018-06-15 | 2021-03-16 | 深圳华大生命科学研究院 | 食管癌肿瘤标志物组合及其应用 |
| CN109633156B (zh) * | 2018-12-19 | 2022-02-22 | 湖南中南大学湘雅口腔医院 | 生物标志物在评估口腔鳞癌危险程度中的应用 |
| CN109825596B (zh) * | 2019-04-19 | 2022-03-15 | 中国医学科学院肿瘤医院 | 食管癌样本的内参miRNA及其应用 |
| CN113151455B (zh) * | 2020-01-22 | 2023-04-21 | 中国药科大学 | 外泌体miR-181b-5p在食管鳞癌诊断和治疗中的应用 |
| JPWO2021162065A1 (enExample) * | 2020-02-10 | 2021-08-19 | ||
| WO2021262919A2 (en) | 2020-06-26 | 2021-12-30 | The Research Foundation For The State University Of New York | 5-halouracil-modified micrornas and their use in the treatment of cancer |
| CN111778339B (zh) * | 2020-08-16 | 2021-01-15 | 徐州医科大学 | 与食管癌相关的miRNA标志物及其应用 |
| CN113736886A (zh) * | 2021-09-14 | 2021-12-03 | 河北医科大学第四医院 | 用于食管癌诊断的生物标志物及其应用 |
| WO2023069510A1 (en) * | 2021-10-19 | 2023-04-27 | The United States Government As Represented By The Department Of Veterans Affairs | Cannabinoid compositions for gastroesophageal disorders |
| CN113969318A (zh) * | 2021-11-10 | 2022-01-25 | 广东省人民医院 | 组合的焦亡相关基因在食管腺癌预后模型中的应用 |
| CN116121377A (zh) * | 2022-11-01 | 2023-05-16 | 山西医科大学 | 一种食管鳞癌外泌体富含的miRNA作为诊断食管鳞癌的标志物中的应用 |
| CN118957067B (zh) * | 2024-08-12 | 2025-03-18 | 西北大学 | 一种胸部肿瘤诊断标志物cpd及其相关诊断产品和应用 |
Family Cites Families (105)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5015568A (en) * | 1986-07-09 | 1991-05-14 | The Wistar Institute | Diagnostic methods for detecting lymphomas in humans |
| US5202429A (en) * | 1986-07-09 | 1993-04-13 | The Wistar Institute | DNA molecules having human BCL-2 gene sequences |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| ATE120497T1 (de) | 1988-05-09 | 1995-04-15 | Univ Temple | Verfahren zur voraussage der wirksamkeit einer antineoplastichen behandlung bei einzelnen patienten. |
| US5198338A (en) * | 1989-05-31 | 1993-03-30 | Temple University | Molecular probing for human t-cell leukemia and lymphoma |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US6040140A (en) * | 1991-12-11 | 2000-03-21 | Thomas Jefferson University | Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities |
| US5633135A (en) * | 1991-12-11 | 1997-05-27 | Thomas Jefferson University | Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities |
| WO1993012136A1 (en) * | 1991-12-11 | 1993-06-24 | Thomas Jefferson University | Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| WO1994010343A1 (en) * | 1992-10-29 | 1994-05-11 | Thomas Jefferson University | Methods of detecting micrometastasis of prostate cancer |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US7175995B1 (en) * | 1994-10-27 | 2007-02-13 | Thomas Jefferson University | TCL-1 protein and related methods |
| US6242212B1 (en) * | 1996-02-09 | 2001-06-05 | Thomas Jefferson University | Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins |
| US5928884A (en) * | 1996-02-09 | 1999-07-27 | Croce; Carlo M. | FHIT proteins and nucleic acids and methods based thereon |
| US5849902A (en) | 1996-09-26 | 1998-12-15 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
| WO1998035707A1 (en) * | 1997-02-18 | 1998-08-20 | Thomas Jefferson University | Compositions that bind to pancreatic cancer cells and methods of using the same |
| CA2335315A1 (en) * | 1998-07-20 | 2000-01-27 | Thomas Jefferson University | Nitrilase homologs |
| WO2000005419A1 (en) * | 1998-07-24 | 2000-02-03 | Yeda Research And Development Company Ltd. | Prevention of metastasis with 5-aza-2'-deoxycytidine |
| US7141417B1 (en) * | 1999-02-25 | 2006-11-28 | Thomas Jefferson University | Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene |
| EP1309726B2 (en) | 2000-03-30 | 2018-10-03 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
| EP1276879A4 (en) * | 2000-04-11 | 2004-12-22 | Univ Jefferson | MUIR-TORRE-LIKE SYNDROME IN Fhit-DEFECTIVE MICE |
| US7060811B2 (en) * | 2000-10-13 | 2006-06-13 | Board Of Regents, The University Of Texas System | WWOX: a tumor suppressor gene mutated in multiple cancers |
| US20020173478A1 (en) | 2000-11-14 | 2002-11-21 | The Trustees Of The University Of Pennsylvania | Post-transcriptional gene silencing by RNAi in mammalian cells |
| US20040033502A1 (en) * | 2001-03-28 | 2004-02-19 | Amanda Williams | Gene expression profiles in esophageal tissue |
| EP2390328A1 (en) * | 2001-09-28 | 2011-11-30 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | MicroRNA molecules |
| US7371736B2 (en) * | 2001-11-07 | 2008-05-13 | The Board Of Trustees Of The University Of Arkansas | Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss |
| GB0128898D0 (en) * | 2001-12-03 | 2002-01-23 | Biotech Res Ventures Pte Ltd | Materials and methods relating to the stabilization and activation of a tumour suppressor protein |
| WO2003069853A1 (en) * | 2002-02-12 | 2003-08-21 | Nokia Corporation | Method for controlling data transmission, and data transmission system |
| US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| WO2003086445A1 (en) * | 2002-04-08 | 2003-10-23 | Ciphergen Biosystems, Inc. | Serum biomarkers in hepatocellular carcinoma |
| EP1499182B1 (en) * | 2002-04-29 | 2009-10-28 | Thomas Jefferson University | Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
| US8119610B2 (en) | 2002-05-31 | 2012-02-21 | The Regents Of The University Of California | Method for efficient RNA interference in mammalian cells |
| EP1530418A4 (en) * | 2002-05-31 | 2005-10-12 | Univ Leland Stanford Junior | METHOD FOR IDENTIFYING AND INSULATING STEM CELLS AND CANCER STAMPS |
| US7148342B2 (en) | 2002-07-24 | 2006-12-12 | The Trustees Of The University Of Pennyslvania | Compositions and methods for sirna inhibition of angiogenesis |
| WO2004033659A2 (en) * | 2002-10-11 | 2004-04-22 | Thomas Jefferson University | Novel tumor suppressor gene and compositions and methods for making and using the same |
| US20040152112A1 (en) * | 2002-11-13 | 2004-08-05 | Thomas Jefferson University | Compositions and methods for cancer diagnosis and therapy |
| WO2004071464A2 (en) * | 2003-02-12 | 2004-08-26 | Johns Hopkins University School Of Medicine | Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| CA2518791A1 (en) * | 2003-03-11 | 2004-09-23 | Qlt Usa Inc. | Formulations for cell-schedule dependent anticancer agents |
| US20050069918A1 (en) * | 2003-05-29 | 2005-03-31 | Francois Claret | JAB1 as a prognostic marker and a therapeutic target for human cancer |
| US8106180B2 (en) * | 2003-08-07 | 2012-01-31 | Whitehead Institute For Biomedical Research | Methods and products for expression of micro RNAs |
| US20050037362A1 (en) * | 2003-08-11 | 2005-02-17 | Eppendorf Array Technologies, S.A. | Detection and quantification of siRNA on microarrays |
| JP2007506425A (ja) * | 2003-09-24 | 2007-03-22 | オンコセラピー・サイエンス株式会社 | 肝細胞癌を診断する方法 |
| CA2554818A1 (en) * | 2004-02-09 | 2005-08-25 | Thomas Jefferson University | Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features |
| US20060134639A1 (en) * | 2004-04-06 | 2006-06-22 | Huffel Christophe V | Method for the determination of cellular transcriptional regulation |
| JP5697297B2 (ja) * | 2004-05-14 | 2015-04-08 | ロゼッタ ジノミクス リミテッド | マイクロｎａｓおよびその使用 |
| EP2290071B1 (en) * | 2004-05-28 | 2014-12-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
| US7635563B2 (en) * | 2004-06-30 | 2009-12-22 | Massachusetts Institute Of Technology | High throughput methods relating to microRNA expression analysis |
| KR20070058441A (ko) * | 2004-07-01 | 2007-06-08 | 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 면역억제성 엑소솜 |
| US20060037088A1 (en) * | 2004-08-13 | 2006-02-16 | Shulin Li | Gene expression levels as predictors of chemoradiation response of cancer |
| US7893034B2 (en) * | 2004-09-02 | 2011-02-22 | Yale University | Regulation of oncogenes by microRNAs |
| US7642348B2 (en) * | 2004-10-04 | 2010-01-05 | Rosetta Genomics Ltd | Prostate cancer-related nucleic acids |
| FR2877350B1 (fr) * | 2004-11-03 | 2010-08-27 | Centre Nat Rech Scient | IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE |
| EP2314688B1 (en) * | 2004-11-12 | 2014-07-16 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
| US20060185027A1 (en) * | 2004-12-23 | 2006-08-17 | David Bartel | Systems and methods for identifying miRNA targets and for altering miRNA and target expression |
| US20070099196A1 (en) * | 2004-12-29 | 2007-05-03 | Sakari Kauppinen | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs |
| US20090123912A1 (en) * | 2005-01-25 | 2009-05-14 | Rosetta Inpharmatics Llc | Methods for quantitating small RNA molecules |
| CN103251946A (zh) * | 2005-02-23 | 2013-08-21 | 健泰科生物技术公司 | 使用her二聚化抑制剂在癌症患者中延长病情进展前时间或存活 |
| US20070065840A1 (en) * | 2005-03-23 | 2007-03-22 | Irena Naguibneva | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS |
| US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
| AU2006279906B2 (en) * | 2005-08-10 | 2012-05-10 | Alnylam Pharmaceuticals, Inc. | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| US20070092882A1 (en) * | 2005-10-21 | 2007-04-26 | Hui Wang | Analysis of microRNA |
| US8445198B2 (en) * | 2005-12-01 | 2013-05-21 | Medical Prognosis Institute | Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| US7390792B2 (en) * | 2005-12-15 | 2008-06-24 | Board Of Regents, The University Of Texas System | MicroRNA1 therapies |
| ES2524018T3 (es) * | 2006-01-05 | 2014-12-03 | The Ohio State University Research Foundation | Anomalías de la expresión de microARN en tumores pancreáticos endocrinos y acinares |
| WO2007081720A2 (en) * | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| KR101407707B1 (ko) * | 2006-04-03 | 2014-06-19 | 산타리스 팔마 에이/에스 | Ａｎｔｉ-ｍｉｒｎａ 안티센스 올리고뉴클레오타이드를 함유하는 약학적 조성물 |
| AU2007243475B2 (en) * | 2006-04-24 | 2013-02-07 | The Ohio State University Research Foundation | Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in miR155 transgenic mice |
| JP2010510964A (ja) * | 2006-09-19 | 2010-04-08 | アシュラジェン インコーポレイテッド | 治療的介入の標的としての、ｍｉＲ−１５、ｍｉＲ−２６、ｍｉＲ−３１、ｍｉＲ−１４５、ｍｉＲ−１４７、ｍｉＲ−１８８、ｍｉＲ−２１５、ｍｉＲ−２１６、ｍｉＲ−３３１、ｍｍｕ−ｍｉＲ−２９２−３ｐによって調節される遺伝子および経路 |
| CA2663878A1 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-200 regulated genes and pathways as targets for therapeutic intervention |
| AU2007299828C1 (en) * | 2006-09-19 | 2014-07-17 | Interpace Diagnostics, Llc | MicroRNAs differentially expressed in pancreatic diseases and uses thereof |
| US8071292B2 (en) * | 2006-09-19 | 2011-12-06 | The Ohio State University Research Foundation | Leukemia diagnostic methods |
| JP5501766B2 (ja) * | 2006-11-01 | 2014-05-28 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 肝細胞癌における生存および転移を予測するためのマイクロｒｎａ発現サイン |
| CN101316935B (zh) * | 2006-11-28 | 2012-02-29 | 博奥生物有限公司 | 一种用于诊断食道癌的芯片 |
| US8293684B2 (en) * | 2006-11-29 | 2012-10-23 | Exiqon | Locked nucleic acid reagents for labelling nucleic acids |
| CA2671299A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Functions and targets of let-7 micro rnas |
| CA2671294A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-21 regulated genes and pathways as targets for therapeutic intervention |
| AU2007333106A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | miR-20 regulated genes and pathways as targets for therapeutic intervention |
| CN101622350A (zh) * | 2006-12-08 | 2010-01-06 | 奥斯瑞根公司 | 作为干预治疗靶标的miR-126调控基因和通路 |
| US8034560B2 (en) * | 2007-01-31 | 2011-10-11 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia (AML) |
| ATE553196T1 (de) * | 2007-02-27 | 2012-04-15 | Rosetta Genomics Ltd | Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod |
| EP2126584B1 (en) * | 2007-03-16 | 2012-12-19 | CovalX AG | Direct mass spectrometric analysis of drug candidates targeting protein complexes |
| JP5592251B2 (ja) * | 2007-04-30 | 2014-09-17 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 膵臓癌を正常な膵臓機能および／または慢性膵炎と識別する方法 |
| US20090005336A1 (en) * | 2007-05-08 | 2009-01-01 | Zhiguo Wang | Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions |
| US20090131354A1 (en) * | 2007-05-22 | 2009-05-21 | Bader Andreas G | miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| WO2008154098A2 (en) * | 2007-06-07 | 2008-12-18 | Wisconsin Alumni Research Foundation | Reagents and methods for mirna expression analysis and identification of cancer biomarkers |
| US8053186B2 (en) * | 2007-06-15 | 2011-11-08 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
| CA2676113C (en) * | 2007-07-25 | 2014-07-08 | University Of Louisville Research Foundation, Inc. | Exosome-associated microrna as a diagnostic marker |
| US20090061424A1 (en) * | 2007-08-30 | 2009-03-05 | Sigma-Aldrich Company | Universal ligation array for analyzing gene expression or genomic variations |
| US20090123933A1 (en) * | 2007-11-12 | 2009-05-14 | Wake Forest University Health Sciences | Microrna biomarkers in lupus |
| EP2604704B1 (en) * | 2008-02-01 | 2018-10-03 | The General Hospital Corporation | Use of microvesicles in diagnosis and prognosis of brain tumor |
| WO2009108860A2 (en) * | 2008-02-28 | 2009-09-03 | The Ohio University Rasearch Foundation | Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders |
| US20110107440A1 (en) * | 2008-06-04 | 2011-05-05 | Andor Pivarcsi | Skin cancer associated micrornas |
| US20100021734A1 (en) * | 2008-07-22 | 2010-01-28 | Covalent Materials Corporation | Ceramic particles and producing method thereof |
| KR101031305B1 (ko) * | 2008-07-23 | 2011-04-29 | 국립암센터 | 마이크로ｒｎａ-21 저해제를 포함하는 방사선 민감성증진용 조성물 |
| US8728745B2 (en) * | 2008-09-04 | 2014-05-20 | Ventana Medical Sysems, Inc. | Method for prediction of the progression risk of tumors |
| CA2715518A1 (en) * | 2009-09-23 | 2011-03-23 | Wilson Roa | Microrna expression profiles associated with lung cancer |
| CN102844661B (zh) * | 2010-02-11 | 2014-06-25 | 香港理工大学 | 胃癌的生物标志物及其应用 |
-
2008
- 2008-10-10 CA CA2702241A patent/CA2702241A1/en not_active Abandoned
- 2008-10-10 EP EP08838376A patent/EP2212440A4/en not_active Withdrawn
- 2008-10-10 WO PCT/US2008/079482 patent/WO2009049129A1/en not_active Ceased
- 2008-10-10 AU AU2008310704A patent/AU2008310704B2/en not_active Ceased
- 2008-10-10 US US12/682,318 patent/US20100285471A1/en not_active Abandoned
- 2008-10-10 CN CN200880116343.7A patent/CN101861401B/zh not_active Expired - Fee Related
- 2008-10-10 CN CN201410040769.6A patent/CN103937876B/zh not_active Expired - Fee Related
- 2008-10-10 JP JP2010529072A patent/JP5723156B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011501943A5 (enExample) | ||
| Shen et al. | MicroRNAs as potential biomarkers in human solid tumors | |
| Fiorino et al. | MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B-and C-related-hepatocellular-carcinoma | |
| A Macha et al. | MicroRNAs (miRNAs) as biomarker (s) for prognosis and diagnosis of gastrointestinal (GI) cancers | |
| Budhu et al. | Identification of metastasis‐related microRNAs in hepatocellular carcinoma | |
| Del Vescovo et al. | MicroRNAs as lung cancer biomarkers | |
| JP2013502931A5 (enExample) | ||
| JP5995721B2 (ja) | 肺疾患のｍｉＲＮＡバイオマーカー | |
| US7943318B2 (en) | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer | |
| EP2634266B1 (en) | miRNA biomarkers of prostate disease | |
| Nohata et al. | MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma | |
| JP2011517283A5 (enExample) | ||
| JP2012231801A5 (enExample) | ||
| JP2010538653A5 (enExample) | ||
| JP2009528070A5 (enExample) | ||
| WO2007081680A2 (en) | Microrna expression abnormalities in pancreatic endocrine and acinar tumors | |
| JP2014513528A5 (enExample) | ||
| Song et al. | Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis | |
| Janiszewska et al. | microRNAs are important players in head and neck carcinoma: a review | |
| Hannafon et al. | miRNAs as biomarkers for predicting the progression of ductal carcinoma in situ | |
| Wang et al. | miRNA for diagnosis and clinical implications of human hepatocellular carcinoma | |
| Sharma et al. | miRNA–mRNA crosstalk in esophageal cancer: From diagnosis to therapy | |
| Gao et al. | Clinical application of microRNA in gastric cancer in Eastern Asian area | |
| Emmett et al. | An update on cellular MicroRNA expression in human papillomavirus-associated head and neck squamous cell carcinoma | |
| Wang | Predicting cancer-related MiRNAs using expression profiles in tumor tissue |